Abbott Ireland Diagnostics Division: FDA filings under this applicant name

FDA lists 8 510(k) clearances under the applicant name “Abbott Ireland Diagnostics Division” (first 2021, latest 2023), across 8 product codes in 1 review panel. Median 510(k) review time under this name: 424 days. Since 2017 the median was 424 days, against 242 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under Abbott, based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20211384
20226460
20231266
20240—
20250—
20260—

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Abbott Ireland Diagnostics Division took a median 424 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 242 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
CDQUrease And Glutamic Dehydrogenase, Urea Nitrogen11
CGXAlkaline Picrate, Colorimetry, Creatinine11
CHHEnzymatic Esterase--Oxidase, Cholesterol11
CIGDiazo Colorimetry, Bilirubin11
CIXBromcresol Green Dye-Binding, Albumin11
CJENitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes11
CJWBromcresol Purple Dye-Binding, Albumin11
JFJCatalytic Methods, Amylase11

Review panels

Most recent Abbott Ireland Diagnostics Division 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K223317Alkaline Phosphatase2CJE2023-07-21266
K223324Total Bilirubin2CIG2022-12-2959
K203597Cholesterol2CHH2022-06-30568
K203771Urea Nitrogen2CDQ2022-05-31524
K210633Amylase2JFJ2022-05-26449
K210452Creatinine2CGX2022-03-22399
K203530Albumin BCP2CJW2022-03-18471
K203248Albumin BCG2CIX2021-11-23384

Recalls

12 product recalls in 5 recall events; 0 initiated in the last five years. Most recent: 2019-02-05.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Abbott Ireland Diagnostics Division?

FDA lists 8 510(k) clearances under the applicant name “Abbott Ireland Diagnostics Division” (first 2021, latest 2023), across 8 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Abbott Ireland Diagnostics Division?

The median time from FDA receipt to decision across 510(k)s cleared under the name Abbott Ireland Diagnostics Division is 424 days. Since 2017: 424 days, versus 242 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Abbott Ireland Diagnostics Division?

The most frequent FDA product codes under this applicant name are CDQ (Urease And Glutamic Dehydrogenase, Urea Nitrogen, 1); CGX (Alkaline Picrate, Colorimetry, Creatinine, 1); CHH (Enzymatic Esterase--Oxidase, Cholesterol, 1).

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.

All FDA device companies · FDA product code lookup